What it does
Advantage Data Vision Limited builds an AI-driven virtual patient simulation system for liver cancer care. It fuses CT/MRI imaging, genomic profiles and clinical history into a digital twin of each patient to predict immunotherapy response, assess metastasis risk and support treatment selection, with a patient app and an encrypted Deep Feature QR code for cross-institution sharing. Two modules are in evaluation at CUHK Shenzhen; the company holds US, China and Hong Kong patents and has signed an investment agreement, with Google Cloud, Roche and HKSTP partnerships.
